Stay informed with the latest headlines
BofA Securities analyst Peter T. Galbo initiated coverage on Primo Brands Corporation (NYSE:PRMB), with a price forecast of $42.Galbo notes that Primo Brands stock is expected to appreciate over the next 12 months as the company realizes cost synergies, targeting $300 million in EBITDA by 2026.If valuation multiples stay steady, this should support growth in […]
Read More
All eyes turn to NVIDIA Corporation (NASDAQ:NVDA) and the company’s AI dominance, new products and questions for the China market when the company reports first-quarter financial results Wednesday after market close.Here are the analyst earnings estimates, what experts are saying ahead of the report and key items to watch.Earnings Estimates: Analysts expect Nvidia to report […]
Read More
JPMorgan on Thursday shared updated thoughts on Ultragenyx Pharmaceutical Inc’s (NASDAQ:RARE) setrusumab program in osteogenesis imperfecta (OI).In a fourth-quarter 2024 press release, the company said patients continue dosing in the Phase 3 Orbit and Cosmic trials, which evaluate setrusumab in pediatric and young adult patients with OI.The randomized, placebo-controlled Phase 3 portion of the Orbit […]
Read More
The U.S. markets have been in a frenzy over the past few days thanks to a new AI model from Chinese company Deepseek. The market reaction has been challenging for chipmakers and semiconductors companies like Nvidia Corp (NASDAQ:NVDA) , Advanced Micro Devices Inc (NASDAQ:AMD), Arm Holdings (NASDAQ:ARM), and others.Nvidia experienced a historic drop in its […]
Read More
Goldman Sachs analyst Noah Poponak expressed views on GE Aerospace‘s (NYSE:GE) fourth-quarter FY24 results.Today, the company reported fourth-quarter adjusted revenue growth of 16% year-over-year to $9.879 billion and GAAP revenue of $10.812 billion. The analyst consensus was $9.604 billion.Adjusted EPS for the quarter was $1.32 (+103% Y/Y), beating the consensus of $1.04.GE Aerospace expects FY25 […]
Read More
On Friday, Novo Nordisk A/S (NYSE:NVO) released headline results from the REDEFINE 1 Phase 3 trial in the global REDEFINE program.When evaluating the effects of treatment if all people adhered to treatment, people treated with CagriSema achieved a weight loss of 22.7% after 68 weeks compared to a reduction of 11.8% with cagrilintide 2.4 mg, […]
Read More
The world of autonomous driving is rapidly approaching a key moment: Tesla Inc (NASDAQ:TSLA) is set to hold its Robotaxi event on Oct. 10.What Happened: The Austin, Texas-based car manufacturer is gearing up to make yet another bold move, despite divided public opinion on driverless technology. Nearly 63% of American adults would not ride in […]
Read More
Veteran Wall Street investor Ed Yardeni challenged fears of a U.S. recession on Monday, opposing the prevailing market sentiment that unsettled global equities.“A weak July employment report does not make a recession,” wrote Ed Yardeni, president of Yardeni Research, in a morning note published ahead of the stronger-than-expected ISM Services PMI report. Yardeni argues that […]
Read More
In the stock market, when there is a large amount of trading at a particular price, it tends to make that price important. There will be many traders and investors who bought or sold there, so if a stock trends one way or the other and then reverses, eventually returning to the price, many investors […]
Read More
Ethereum could face a significant correction if it breaks the $3,400 support level, according to trader Ali Charts. What Happened: On Monday, Ali Charts tweeted a warning to traders about a potential bearish scenario for Ethereum (CRYPTO: ETH). If the cryptocurrency breaches the $3,400 support level, it could confirm a bear pennant formation on the […]
Read More